In last trading session, Outset Medical Inc (NASDAQ:OM) saw 0.51 million shares changing hands with its beta currently measuring 2.04. Company’s recent per share price level of $0.55 trading at $0.0 or -0.09% at ring of the bell on the day assigns it a market valuation of $29.80M. That closing price of OM’s stock is at a discount of -849.09% from its 52-week high price of $5.22 and is indicating a premium of 20.0% from its 52-week low price of $0.44. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.73 million shares which gives us an average trading volume of 1.10 million if we extend that period to 3-months.

For Outset Medical Inc (OM), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.80. Splitting up the data highlights that, out of 8 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.26 in the current quarter.

Outset Medical Inc (NASDAQ:OM) trade information

Upright in the red during last session for losing -0.09%, in the last five days OM remained trading in the red while hitting it’s week-highest on Tuesday, 03/11/25 when the stock touched $0.55 price level, adding 9.78% to its value on the day. Outset Medical Inc’s shares saw a change of -50.18% in year-to-date performance and have moved -7.68% in past 5-day. Outset Medical Inc (NASDAQ:OM) showed a performance of -29.10% in past 30-days. Number of shares sold short was 11.23 million shares which calculate 11.34 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 6 to the stock, which implies a rise of 90.83% to its current value. Analysts have been projecting 3 as a low price target for the stock while placing it at a high target of 34. It follows that stock’s current price would drop -445.45% in reaching the projected high whereas dropping to the targeted low would mean a loss of -445.45% for stock’s current value.

Outset Medical Inc (OM) estimates and forecasts

This year revenue growth is estimated to rise 5.78% from the last financial year’s standing.

5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 27.81M for the same. And 5 analysts are in estimates of company making revenue of 29.14M in the next quarter. Company posted 28.17M and 27.39M of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -4.06% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 42.57% while estimates for its earnings growth in next 5 years are of 29.58%.

Outset Medical Inc (NASDAQ:OM)’s Major holders

Insiders are in possession of 0.45% of company’s total shares while institution are holding 9.43 percent of that, with stock having share float percentage of 9.47%. Investors also watch the number of corporate investors in a company very closely, which is 9.43% institutions for Outset Medical Inc that are currently holding shares of the company. FMR LLC is the top institutional holder at OM for having 7.7 million shares of worth $29.63 million. And as of 2024-06-30, it was holding 15.1214 of the company’s outstanding shares.

The second largest institutional holder is AMERIPRISE FINANCIAL INC, which was holding about 5.2 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.2162 of outstanding shares, having a total worth of $20.02 million.

On the other hand, Fidelity Select Portfolios – Medical Technology & Devices Port and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 3.3 shares of worth $1.82 million or 6.12% of the total outstanding shares. The later fund manager was in possession of 1.65 shares on Dec 31, 2024 , making its stake of worth around $0.91 million in the company or a holder of 3.06% of company’s stock.